Teva Pharmaceutical has a total of 12,798 patents globally, out of which 4,457 are granted. Out of these 12,798 patents, 26.40% are currently active. Teva has filed the maximum number of patents in the United States of America, followed by Europe (EPO) and China, making these regions its major innovation hubs. In line with this, the United States of America also serves as Teva’s primary R&D focus area. The company is headquartered in Tel Aviv, Israel, which is also the origin country of Teva Pharmaceutical.
Teva Pharmaceutical founded in 1901 and headquartered in Israel, is one of the world’s leading pharmaceutical companies. Teva specializes in the development, manufacturing, and marketing of generic medicines, biosimilar, and specialty pharmaceuticals.
The company’s portfolio covers a wide range of therapeutic areas, including central nervous system disorders, respiratory conditions, oncology, and more. With a global presence and decades of expertise, Teva plays a major role in improving patient access to high-quality, affordable healthcare worldwide.
Do read about some of the most popular patents of Teva Pharmaceutical which have been covered by us in this article and also you can find Teva Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Teva Pharmaceutical patent portfolio.
How many patents does Teva Pharmaceutical have?
Teva Pharmaceutical has a total of 12,798 patents globally. These patents belong to 3,480 unique patent families. Out of 12,798 patents, 3,379 patents are active.
How Many Patents did Teva Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Teva Pharmaceutical Applications Filed | Teva Pharmaceutical Patents Granted |
| 2025 | 25 | 102 |
| 2024 | 81 | 115 |
| 2023 | 174 | 127 |
| 2022 | 199 | 148 |
| 2021 | 263 | 208 |
| 2020 | 152 | 182 |
| 2019 | 232 | 213 |
| 2018 | 272 | 230 |
| 2017 | 473 | 297 |
| 2016 | 597 | 372 |
How many Teva Pharmaceutical patents are Alive/Dead?
Worldwide Patents
How Many Patents did Teva Pharmaceutical File in Different Countries?
Top Countries in which Teva Pharmaceutical Filed Patents
| Country | Patent |
| United States Of America | 2065 |
| Europe | 1456 |
| Japan | 790 |
| Canada | 744 |
| China | 623 |
| Israel | 604 |
| Australia | 477 |
| South Korea | 459 |
| India | 393 |
| Brazil | 331 |
| Mexico | 304 |
| Spain | 301 |
| Eurasia | 281 |
| Hong Kong (S.A.R.) | 277 |
| Taiwan | 184 |
| South Africa | 174 |
| Poland | 162 |
| New Zealand | 148 |
| Argentina | 125 |
| Denmark | 122 |
| Germany | 115 |
| Portugal | 115 |
| Russia | 98 |
| Singapore | 93 |
| Turkey | 89 |
| Croatia | 71 |
| Austria | 69 |
| Slovenia | 63 |
| Ukraine | 62 |
| Hungary | 61 |
| United Kingdom | 49 |
| Norway | 43 |
| Serbia | 39 |
| Uruguay | 30 |
| Philippines | 26 |
| Morocco | 22 |
| Colombia | 22 |
| Ireland | 16 |
| Iceland | 15 |
| Malaysia | 15 |
| Czech Republic | 12 |
| Switzerland | 10 |
| Lithuania | 10 |
| Costa Rica | 9 |
| Chile | 7 |
| Finland | 7 |
| Thailand | 5 |
| Luxembourg | 5 |
| Italy | 5 |
| Tunisia | 4 |
| Indonesia | 4 |
| Netherlands | 3 |
| France | 3 |
| Saudi Arabia | 2 |
| Republic Of Moldova | 2 |
| Cuba | 2 |
| Georgia | 2 |
| Greece | 1 |
| El Salvador | 1 |
| Latvia | 1 |
| Africa | 1 |
| Viet Nam | 1 |
| Ecuador | 1 |
| Bulgaria | 1 |
| Belgium | 1 |
Where are Research Centres of Teva Pharmaceutical Patents Located?
10 Best Teva Pharmaceutical Patents
US20090131485A1 is the most popular patent in the Teva Pharmaceutical portfolio. It has received 502 citations so far from companies like Companies, Abbott Laboratories, Abbvie Inc. and Concert Pharmaceuticals, Inc.
Below is the list of 10 most cited patents of Teva Pharmaceutical:
| Publication Number | Citation Count |
| US20090131485A1 | 502 |
| WO2008051547A1 | 195 |
| WO2008119552A1 | 182 |
| US20070240712A1 | 159 |
| WO2013074633A1 | 140 |
| US8524733B2 | 129 |
| US20090087483A1 | 138 |
| US20110206780A1 | 124 |
| WO2008033523A1 | 133 |
| WO2009064476A1 | 121 |
What Percentage of Teva Pharmaceutical US Patent Applications were Granted?
Teva Pharmaceutical (Excluding its subsidiaries) has filed 1215 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 501 have been granted leading to a grant rate of 47%.
Below are the key stats of Teva Pharmaceutical patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Teva Pharmaceutical?
| Law Firm | Total Applications | Success Rate |
| Hunton Andrews Kurth Llp | 508 | 57.15% |
| Gary J Gershik John P White | 239 | 44.00% |
| Bakerhostetler | 71 | 50.00% |
| Fish & Richardson P C Bo | 54 | 56.60% |
| Carter Deluca & Farrell Llp | 32 | 69.23% |
| Mccarter & English Llp Boston | 29 | 55.56% |
| Pearl Cohen Zedek Latzer Baratz Llp | 19 | 94.12% |
| John P White | 17 | 60.00% |
| Merchant & Gould P C | 17 | 15.63% |
| Cantor Colburn Llp | 14 | 80.00% |
What are Teva Pharmaceutical key innovation segments?
What Technologies are Covered by Teva Pharmaceutical?
The chart below distributes patents filed by Teva Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Teva Pharmaceutical thinks it’s important to protect particular technological inventions.
R&D Focus: How has Teva Pharmaceutical search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Teva Pharmaceutical?
